Peregrine Pharmaceuticals

Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone...

TUSTIN, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Avid Bioservices, Inc. today announced that it is expanding its biomanufacturing capabilities with the installation of two Thermo Scientific HyClone Single-Use Bioreactors...

Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 10th Annual Healthcare Conference

TUSTIN, Calif., November 05, 2008 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. today announced that senior management will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Tuesday, November 11,...

Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008

Presentation to Be Webcast Live On Company's Website - TUSTIN, Calif., October 28, 2008 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing monoclonal antibodies for...

Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008

TUSTIN, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and serious virus infections, today...

Peregrine Pharmaceuticals to Present at BIO Investor Forum 2008 (PR Newswire)

Peregrine Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and serious virus infections, today announced that senior management will present at the...

Avid Bioservices to Serve as Contract Manufacturer for Catalyst Biosciences' Novel Human...

TUSTIN, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Avid Bioservices, Inc. today announced it has signed a manufacturing supply agreement with Catalyst Biosciences, Inc. to produce clinical-grade material in support of their...

Avid Bioservices to Serve as Contract Manufacturer for Catalyst Biosciences' Novel Human...

Avid Bioservices, Inc. today announced it has signed a manufacturing supply agreement with Catalyst Biosciences, Inc. to produce clinical-grade material in support of their clinical candidate, CB 813, an improved version of...